tumor biomarkers

Neoadjuvant nivolumab plus ipilimumab in resectable non-small cell lung cancer
Joshua E Reuss, Valsamo Anagnostou, Tricia R Cottrell, Kellie N Smith, Franco Verde, Marianna Zahurak, Mara Lanis, Joseph C Murray, Hok Yee Chan, Caroline McCarthy, Daphne Wang, James R White, Stephen Yang, Richard Battafarano, Stephen Broderick, Errol Bush, Malcolm Brock, Jinny Ha, David Jones, Taha Merghoub, Janis Taube, Victor E Velculescu, Gary Rosner, Peter Illei, Drew M Pardoll, Suzanne Topalian, Jarushka Naidoo, Ben Levy, Matthew Hellmann, Julie R Brahmer, Jamie E Chaft, Patrick M Forde

Journal for ImmunoTherapy of Cancer Sep 2020, 8 (2) e001282; DOI: 10.1136/jitc-2020-001282
Somatic POLE exonuclease domain mutations elicit enhanced intratumoral immune responses in stage II colorectal cancer
Shaobo Mo, Xiaoji Ma, Yaqi Li, Long Zhang, Ting Hou, Han Han-Zhang, Juanjuan Qian, Sanjun Cai, Dan Huang, Junjie Peng

Journal for ImmunoTherapy of Cancer Aug 2020, 8 (2) e000881; DOI: 10.1136/jitc-2020-000881
M2-like macrophages dictate clinically relevant immunosuppression in metastatic ovarian cancer
Michal Hensler, Lenka Kasikova, Karel Fiser, Jana Rakova, Petr Skapa, Jan Laco, Tereza Lanickova, Ladislav Pecen, Iva Truxova, Sarka Vosahlikova, Irena Moserova, Ivan Praznovec, Vit Drochytek, Martina Rehackova, Tomas Brtnicky, Lukas Rob, Vladimir Benes, Jelena Pistolic, Ludek Sojka, Ales Ryska, Catherine Sautes-Fridman, Wolf Herve Fridman, Lorenzo Galluzzi, Radek Spisek, Jitka Fucikova

Journal for ImmunoTherapy of Cancer Aug 2020, 8 (2) e000979; DOI: 10.1136/jitc-2020-000979
Prediction of immune checkpoint inhibition with immune oncology-related gene expression in gastrointestinal cancer using a machine learning classifier
Zhihao Lu, Huan Chen, Xi Jiao, Wei Zhou, Wenbo Han, Shuang Li, Chang Liu, Jifang Gong, Jian Li, Xiaotian Zhang, Xicheng Wang, Zhi Peng, Changsong Qi, Zhenghang Wang, Yanyan Li, Jie Li, Yan Li, Malcolm Brock, Henghui Zhang, Lin Shen

Journal for ImmunoTherapy of Cancer Aug 2020, 8 (2) e000631; DOI: 10.1136/jitc-2020-000631
Discovery and validation of surface N-glycoproteins in MM cell lines and patient samples uncovers immunotherapy targets
Robyn A A Oldham, Mary L Faber, Theodore R Keppel, Amanda R Buchberger, Matthew Waas, Parameswaran Hari, Rebekah L Gundry, Jeffrey A Medin

Journal for ImmunoTherapy of Cancer Aug 2020, 8 (2) e000915; DOI: 10.1136/jitc-2020-000915
Efficacy of immunotherapy in lung cancer with co-occurring mutations in NOTCH and homologous repair genes
Marco Mazzotta, Marco Filetti, Mario Occhipinti, Daniele Marinelli, Stefano Scalera, Irene Terrenato, Francesca Sperati, Matteo Pallocca, Francesco Rizzo, Alain Gelibter, Andrea Botticelli, Giorgia Scafetta, Arianna Di Napoli, Eriseld Krasniqi, Laura Pizzuti, Maddalena Barba, Silvia Carpano, Patrizia Vici, Maurizio Fanciulli, Francesca De Nicola, Ludovica Ciuffreda, Frauke Goeman, Ruggero De Maria, Andrea Vecchione, Raffaele Giusti, Gennaro Ciliberto, Paolo Marchetti, Marcello Maugeri-Saccà

Journal for ImmunoTherapy of Cancer Aug 2020, 8 (2) e000946; DOI: 10.1136/jitc-2020-000946
Outcomes to first-line pembrolizumab in patients with PD-L1-high (≥50%) non–small cell lung cancer and a poor performance status
Joao V Alessi, Biagio Ricciuti, Elizabeth Jiménez-Aguilar, Fangxin Hong, Zihan Wei, Mizuki Nishino, Andrew J Plodkowski, Peter Sawan, Jia Luo, Hira Rizvi, Brett W Carter, John V Heymach, Mehmet Altan, Matthew Hellmann, Mark Awad

Journal for ImmunoTherapy of Cancer Aug 2020, 8 (2) e001007; DOI: 10.1136/jitc-2020-001007
Impact of body composition on outcomes from anti-PD1 +/− anti-CTLA-4 treatment in melanoma
Arissa C Young, Henry T Quach, Haocan Song, Elizabeth J Davis, Javid J Moslehi, Fei Ye, Grant R Williams, Douglas B Johnson

Journal for ImmunoTherapy of Cancer Jul 2020, 8 (2) e000821; DOI: 10.1136/jitc-2020-000821
Prognostic value of novel immune-related genomic biomarkers identified in head and neck squamous cell carcinoma
Yao Yao, Zhongyi Yan, Senlin Lian, Liangnian Wei, Chao Zhou, Dongju Feng, Yuan Zhang, Jianrong Yang, Ming Li, Yun Chen

Journal for ImmunoTherapy of Cancer Jul 2020, 8 (2) e000444; DOI: 10.1136/jitc-2019-000444
Baseline metabolic tumor volume as a strong predictive and prognostic biomarker in patients with non-small cell lung cancer treated with PD1 inhibitors: a prospective study
David Chardin, Marie Paquet, Renaud Schiappa, Jacques Darcourt, Caroline Bailleux, Michel Poudenx, Aurélie Sciazza, Marius Ilie, Jonathan Benzaquen, Nicolas Martin, Josiane Otto, Olivier Humbert

Journal for ImmunoTherapy of Cancer Jul 2020, 8 (2) e000645; DOI: 10.1136/jitc-2020-000645

Main menu

tumor biomarkers

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

tumor biomarkers

Pages